Incannex Healthcare Stock-Based Compensation Growth & History (IXHL)
Incannex Healthcare's stock-based compensation was $2.6M for fiscal 2025.
View full Incannex Healthcare company overviewIncannex Healthcare annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $2.6M | −$6.3M | −70.78% |
| 2024 | 2024-06-30 | $8.9M | $6.8M | +315.45% |
| 2023 | 2023-06-30 | $2.1M | $684,450 | +46.73% |
| 2022 | 2022-06-30 | $1.5M | $864,507 | +144.07% |
| 2021 | 2021-06-30 | $600,043 | $34,595 | +6.12% |
| 2020 | 2020-06-30 | $565,448 | — | — |
Incannex Healthcare quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $1.5M | $1.1M | +252.28% |
| Q2 2026 | 2025-12-31 | $2.3M | $1.8M | +423.91% |
| Q1 2026 | 2025-09-30 | $2.6M | $2.2M | +472.11% |
| Q4 2025 | 2025-06-30 | $1.3M | −$2.0M | −61.17% |
| Q3 2025 | 2025-03-31 | $417,000 | −$1.7M | −80.27% |
| Q2 2025 | 2024-12-31 | $435,000 | −$2.8M | −86.70% |
| Q1 2025 | 2024-09-30 | $459,000 | $258,000 | +128.36% |
| Q4 2024 | 2024-06-30 | $3.3M | — | — |
| Q3 2024 | 2024-03-31 | $2.1M | $1.6M | +298.12% |
| Q2 2024 | 2023-12-31 | $3.3M | — | — |
| Q1 2024 | 2023-09-30 | $201,000 | — | — |
| Q3 2023 | 2023-03-31 | $531,000 | — | — |
Incannex Healthcare stock-based compensation trends
Over the last five fiscal years, Incannex Healthcare's stock-based compensation increased from $565,448 to $2.6M, a change of $2.0M. The latest reported quarter, Q3 2026, shows $1.5M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Incannex Healthcare source filings ↗